Retraction: Biocompatible dextran-coated gadolinium-doped cerium oxide nanoparticles as MRI contrast agents with high T1 relaxivity and selective cytotoxicity to cancer cells

Abstract

Retraction of ‘Biocompatible dextran-coated gadolinium-doped cerium oxide nanoparticles as MRI contrast agents with high T1 relaxivity and selective cytotoxicity to cancer cells’ by A. L. Popov et al., J. Mater. Chem. B, 2021, 9, 6586–6599, https://doi.org/10.1039/D1TB01147B.

Associated articles

Article information

Article type
Retraction
Submitted
29 May 2025
Accepted
29 May 2025
First published
05 Jun 2025
This article is Open Access
Creative Commons BY license

J. Mater. Chem. B, 2025, Advance Article

Retraction: Biocompatible dextran-coated gadolinium-doped cerium oxide nanoparticles as MRI contrast agents with high T1 relaxivity and selective cytotoxicity to cancer cells

A. L. Popov, M. A. Abakumov, I. V. Savintseva, A. M. Ermakov, N. R. Popova, O. S. Ivanova, D. D. Kolmanovich, A. E. Baranchikov and V. K. Ivanov, J. Mater. Chem. B, 2025, Advance Article , DOI: 10.1039/D5TB90094H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements